Clinical Trials

The Department of Urology has over 20 years of experience in human-studies research and conducting clinical trials in a number of disease areas. Approximately 150 trials have been completed with enrollment on target. These trials have included investigator-initiated and industry trials. We have worked with most of the major pharmaceutical companies in all phases of the clinical trial spectrum. Sponsor satisfaction with our team is consistently high, frequently resulting in subsequent trials with the same sponsor(s).

Below is a list of our active clinical trials.

Currently Enrolling Patients

Bond 003

To evaluate the activity of intravesical (IVE) administration of CG0070 in patients with tissue pathology confirmed non-muscular invasive bladder cancer (NMIBC) who have Bacillus-Calmette-Guerin (BCG) unresponsive disease, with either carcinoma in situ with or without Ta/T1 disease

Learn more about this trial

PI: Amy Luckenbaugh, MD

CISTO Study – NMIBC

The Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer.

Learn more about this trial

PI: Kristen Scarpato, MD

Cook Myosite

CELLEBRATE: An Adaptive, Two-Stage, Double-Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence.

Learn more about this study

PI: Roger Dmochowski, MD

CxBladder

Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design.

Learn more about this trial

PI: Kristen Scarpato, MD

Medtronic Registry Study

Medtronic Product Surveillance Registry (PSR).

Learn more about this study

PI: Melissa Kaufman, MD

Empiric Versus Selective Prevention Strategies for Kidney Stone Disease

The aims of this study are to conduct a clinical trial comparing two major strategies for kidney stone prevention.

Learn more about this study.

PI: Ryan Hsi, MD

Mini-PCNL vs Standard PCNL

Standard vs Mini-PCNL for the Treatment of Stone Disease

Learn more about this trial

PI: Nicole Miller, MD

MOSES in Stone URS RCT

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

Learn more about this trial

PI: Nicole Miller, MD

Recurrent UTIs and Kidney Stones

Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections. This study will assess patients who have recurrent urinary tract infections and kidney stones which are not blocking the kidney or causing other problems.

Learn more about this trial

PI: Ryan Hsi, MD

Ureteral Stent Trial

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial. The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.

Learn more about this trial

PI: Ryan Hsi, MD

Image Guided Surgery for Partial Nephrectomy

Patient-specific, touch-based registration during robotic, image-guided partial nephrectomy

Learn more about this study

PI: Duke Herrell, MD

Enrollment Closed, Study In-Progress

Altor - QUILT-3.032

A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BHG) in Combination with ALT-803 in Patients with BCG Unresponsive High-Grade Non-Muscle Invasive Bladder Cancer – CA-ALT-803-01-16.

Learn more about this trial

PI: Sam S. Chang, MD

Janssen

Neo-adjuvant and adjuvant apalutamide/placebo plus ADT in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy

Learn more about this study

PI: Kelvin Moses, MD

Myriad Prolaris

Long-Term Prospective Registry in Prostate Cancer Patients from Diverse Urology Practice Settings Following Prolaris Testing

Learn more about this trial

PI: Kelvin Moses, MD

EMBARK: Medivation

A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy

Learn more about this trial

PI: David Penson, MD

DAROL

A Study in Which Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat with Darolutamide has been Made Before Enrollment are Observed and Certain Outcomes are Described

Learn more about this trial

PI: Kelvin Moses, MD

MDx Health – PRIORITY Study

Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY Study.

Learn more about this study

PI: Sam S. Chang, MD

EDRN – MRI Study

NCI Early Detection Research Network – EDRN Prostate MRI Biomarker Study and Reference Set.

Learn more about this trial

PI: Dan Barocas, MD